Abstract
To facilitate long-term venous access in patients receiving chemotherapy, a subcutaneous totally implantable system (Port-a-Cath, Phamacia) has been used in 14 patients. The method of implantation and the advantages over conventional central venous catheters are discussed. The expense of the system necessitates careful patient selection.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Akimaru K., Uchiyama K., Saito M., Ishimura Y., Kanauchi S., Shoji T. Subcutaneous portal reservoir for chemotherapy of metastatic carcinoma of the liver. Surg Gynecol Obstet. 1984 Jan;158(1):93–94. [PubMed] [Google Scholar]
- Bothe A., Jr, Piccione W., Ambrosino J. J., Benotti P. N., Lokich J. J. Implantable central venous access system. Am J Surg. 1984 Apr;147(4):565–569. doi: 10.1016/0002-9610(84)90023-0. [DOI] [PubMed] [Google Scholar]
- Peters J. L., Belsham P. A., Taylor B. A., Watt-Smith S. Long-term venous access. Br J Hosp Med. 1984 Nov;32(5):230, 234-42. [PubMed] [Google Scholar]
- Sagor G., Mitchemere P., Layfield J., Prentice H. G., Kirk R. M. Prolonged access to the venous system using the Hickman right atrial catheter. Ann R Coll Surg Engl. 1983 Jan;65(1):47–49. [PMC free article] [PubMed] [Google Scholar]